Search

everythinglearnresearchcommunity

for

Search:↓

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Islamic perspectives in Malaysia raise ethical concerns about using stem cells, especially from embryos, for beauty and medical treatments.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

Stem cell research and regenerative medicine have made significant advancements in treating various diseases and conditions.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Stem-cell therapy shows promise for skin conditions but needs more research.

Stem cell therapy shows promise for treating skin disorders.

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

Bone-marrow and epidermal stem cells help heal wounds differently, with bone-marrow cells aiding in blood vessel formation and epidermal cells in hair growth.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Transplant success has improved with better immunosuppressive drugs and donor matching.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Neonatal mesenchymal stem cell therapy shows promise for treating hair loss but needs more research.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Stem cell therapies may help improve symptoms and quality of life for people with epidermolysis bullosa.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.